Transparency Market Research (TMR) has published a new report
titled, ‘Autoimmune Disease Diagnostics Market - Global Industry Analysis,
Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report,
the global autoimmune disease diagnostics market was valued at US$ 14.4 Bn in
2018 and is projected to expand at a CAGR of 3.8% from 2019 to
2027.
Read
Report Overview -
https://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html
Overview
·
In
autoimmune disease body's immune system attacks its own healthy cells. There
are at least 80 types of autoimmune diseases. Autoimmune disease diagnostics
include various tests such as antinuclear antibody test, autoantibody test,
complete blood count, comprehensive metabolic panel, and urinalysis that aid in
the diagnosis of autoimmune diseases
·
North
America was the largest market for autoimmune disease diagnostics in 2018 due
to increased awareness about advanced diagnostic techniques and increasing
government initiatives. For instance, the American Autoimmune Related Diseases
Association, Inc. (AARDA) and the National Institutes of Health (NIH) initiated
different programs for the development and advancement of autoimmune disease
treatment and diagnosis in the U.S.
·
Asia
Pacific is likely to be a highly lucrative market for autoimmune disease
diagnostics and it is expected to expand at a high CAGR during the forecast
period. Adoption of new and sophisticated technologies, advances in diagnostic
technologies, and increasing partnership of governments with private players
and clinical laboratories are likely to propel the growth of market during the
forecast period. For instance, India-based SRL Diagnostics partnered with state
governments to set up and operate 24 labs in large state-run hospitals in
various districts.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5351
Growing Awareness
among People about Autoimmune Diseases and High Prevalence of Autoimmune
Diseases across the World to Drive Market
·
Increasing awareness and knowledge about autoimmune diseases among
patients and care-givers would significantly contribute to the growth of the
autoimmune disease diagnostics market. Furthermore, governments across
countries are taking various initiatives and organizing programs in order to
create awareness among the people about autoimmune diseases. For instance, the
American Autoimmune Related Diseases Association, Inc. (AARDA) and the National
Institutes of Health (NIH) initiated various programs for the development and
advancement of autoimmune disease treatment and diagnosis in the U.S.
·
Rising prevalence of autoimmune diseases is likely to fuel the growth of
the autoimmune disease diagnostics market. Therefore, consistent increase in
the autoimmune patient population across the world has been identified as one
of the major factors driving the autoimmune disease diagnostics market.
Request COVID Analysis on Autoimmune Disease Diagnostics Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=5351
Autoantibody Test
Segment to Dominate Market
·
Based on test type, the global autoimmune disease diagnostics market has
been divided into antinuclear antibody test, autoantibody test, complete blood
count (CBC), comprehensive metabolic panel, c-reactive protein (CRP) test,
erythrocyte sedimentation rate (ESR), urinalysis and others.
·
Autoantibody test segment dominated the global autoimmune disease
diagnostics market in 2018 and the trend is projected to continue during the
forecast period. Autoantibody tests are performed when a patient is suffering
from chronic, progressive arthritic symptoms, fatigue, fever, and muscle weakness.
Initially, antinuclear antibody (ANA) test is performed (a primary test to
evaluate a person for autoimmune disorders) and is frequently followed up with
other specific autoantibody tests such as anti-Sjögren’s syndrome A
(anti-SSA/Ro), anti-double strand DNA (anti-dsDNA), anti-Sjögren’s syndrome B
(anti-SSB/La), and anti-ribonucleic protein (anti-RNP), etc.
·
An article published by the American Association for Clinical Chemistry,
stated that over 32 million people in the U.S. have
autoantibodies, with antinuclear antibody the most prevalent and common type of
antibodies present among women, older individuals, and African-Americans
Rheumatoid
Arthritis to be Highly Lucrative Segment
·
In terms of disease type, the global autoimmune disease diagnostics market
has been classified into Graves’ disease, Hashimoto’s thyroiditis, multiple
sclerosis, rheumatoid arthritis, systemic lupus erythematosus, type 1 diabetes,
and others.
·
Rheumatoid Arthritis segment dominated the autoimmune disease
diagnostics market as well as growing with the highest CAGR in the forecast
period due to rising prevalence of diseases, increase in global health care
expenditure and growing public awareness about autoimmune diseases. The annual
incidence of Rheumatoid Arthritis in the U.S. and northern European countries
is estimated to be approximately 40 per 100,000 persons.
·
RA is diagnosed based on the result of joint X-rays and a rheumatoid
factor (RF). The baseline laboratory evaluation includes complete blood count
(CBC) with differential, erythrocyte sedimentation rate (ESR), and C-reactive
protein tests.
Request Customization on Autoimmune
Disease Diagnostics Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=5351
North America to
Dominate Global Market
·
In terms of region, the global autoimmune disease diagnostics market has
been segmented into North America, Europe, Asia Pacific, Latin America, and
Middle East & Africa. North America dominated the global autoimmune disease
diagnostics market in 2018, followed by Europe. The dominance of these two
regions can be attributed to increasing prevalence of autoimmune diseases,
rising awareness among people about advanced laboratory tests, and growing
health care expenditure.
·
North America accounted for major share of the global autoimmune disease
diagnostics market in 2018, primarily due to high awareness about procedures
and advanced laboratory techniques, increase in patient pool, and high health
care expenditure. American Autoimmune Related Diseases Association, Inc.
(AARDA) initiated the formation of the Center for Autoimmune Disease
Research at Johns Hopkins University Medical Center and NIH established
Centers of Excellence in autoimmune diseases.
·
Emerging markets in Asia Pacific holds immense growth potential due to
factors such as rise in the prevalence of autoimmune diseases, increase in the
geriatric population, increasing government initiatives, and rise in health
care infrastructure
Buy Autoimmune Disease Diagnostics Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=5351<ype=S
Competitive
Landscape
·
The global autoimmune disease diagnostics market is fragmented in terms
of number of players. Key players in the global market include Abbott
Laboratories, Inc., Beckman Coulter, Inc. , bioMérieux SA, Bio-Rad
Laboratories, F. Hoffmann-La, Roche Ltd., Inova Diagnostics, Inc., Quest
Diagnostics, SQI Diagnostics, Inc., Siemens Healthcare among others
The global autoimmune disease diagnostics market has been segmented as follows:
·
Global Autoimmune Disease Diagnostics Market, by
Test Type
o Antinuclear
Antibody Test
o Autoantibody Test
o Complete Blood
Count (CBC)
o Comprehensive
Metabolic Panel
o C-reactive Protein
(CRP) Test
o Erythrocyte
Sedimentation Rate (ESR)
o Urinalysis
o Others
·
Global Autoimmune Disease Diagnostics Market, by
Disease Type
o Graves’ Disease
o Hashimoto’s
Thyroiditis
o Multiple Sclerosis
o Rheumatoid
Arthritis
o SLE (Lupus)
o Type 1 Diabetes
o Others
·
Global Autoimmune Disease Diagnostics Market, by
Region
·
North America
o U.S.
o Canada
·
Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Rest of Europe
·
Asia Pacific
o China
o India
o Japan
o Australia & New
Zealand
o Rest of Asia
Pacific
·
Latin America
o Brazil
o Mexico
o Rest of Latin
America
·
Middle East & Africa
o GCC Countries
o South Africa
o Rest of Middle East
& Africa
About Us
Transparency Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking insight
for thousands of decision makers. Our experienced team of analysts,
researchers, and consultants, uses proprietary data sources and various tools
and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research
experts, so that it always reflects the latest trends and information. With a broad
research and analysis capability, Transparency Market Research employs rigorous
primary and secondary research techniques in developing distinctive data sets
and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
